However, standard clinical PCa evaluation using digital rectal examination (DRE) and PSA testing may be of limited value due to confounding factors often observed in patients with clinical BOO, such as prostate enlargement, urinary retention, or presence of an indwelling transurethral catheter. This evidence concerns the gene KLK3 and benign prostatic hyperplasia.